Research groups
Colleges
Albert Prats-Uribe
MD MPH FFPH
Senior Clinical Researcher in Public Health and Epidemiology
Albert Prats-Uribe joined NDORMS in 2018 as a DPhil student. His research is focused on medical devices and COVID-19 epidemiology.
Key publications
-
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
Journal article
Prats-Uribe A. et al, (2021), Bmj, 373
-
Excess cases of influenza suggest an earlier start to the coronavirus epidemic in Spain than official figures tell us: an analysis of primary care electronic medical records from over 6 million people from Catalonia
Coma E. et al, (2020)
-
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.
Journal article
Burn E. et al, (2020), Nat commun, 11
-
Evidences supporting the inclusion of immigrants in the universal health care coverage
Journal article
Prats Uribe A., (2020), European journal of public health
-
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
LANE J. et al, (2020)
-
Hospitalization and 30-day fatality in 121,263 COVID-19 outpatient cases
Prieto-Alhambra D. et al, (2020)
-
Ethnicity, comorbidity, socioeconomic status, and their associations with COVID-19 infection in England: a cohort analysis of UK Biobank data
Prats-Uribe A. et al, (2020)
Recent publications
-
Venous Thromboembolism in Ambulatory Covid-19 patients: Clinical and Genetic Determinants
Xie J. et al, (2022)
-
Comparative effectiveness of the BNT162b2 and ChAdOx1 vaccines against Covid-19 in people over 50.
Journal article
Xie J. et al, (2022), Nat commun, 13
-
The impact of COVID passport mandates on the number of cases of and hospitalizations with COVID-19 in the UK: a difference-in-differences analysis
López-Güell K. et al, (2022)
-
Random effects modelling vs logistic regression for the inclusion of cluster level covariates in propensity scores for medical device and surgical epidemiology
Du M. et al, (2022)
-
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.
Journal article
Williams RD. et al, (2022), Bmc med res methodol, 22